Thus, our results revealed that PREP inhibition driven by KYP-2047 administration suppressed the angiogenic process via VEGF/eNOS modulation, influencing the earliest stages of vascular development induced by intestinal ischemia-reperfusion. The gene discussed is VEGFA; the disease is ischemia.